Advertise on podcast: Springer Health+ IME: Podcast to Practice

Rating

★★★★★

from

1 reviews

Description

Podcast to Practice is the expert-led independent medical educational series aimed at healthcare professionals, brought to you by Springer Health+ IME. Each episode features leading clinical experts in their respective fields, covering a broad range of disease states from the well studied oncology, to lesser known rare diseases. Podcast to Practice discusses latest evidence-based research, clinical guidelines and expert discussions around diagnosis, therapies, and patient management, inspiring healthcare professionals to maximise their learning and make measurable change in their own clinical practice. Podcast to Practice is a production of Springer Health+ IME, the global independent medical educational provider. More info is available at https://ime.springerhealthplus.com

Unlock Springer Health+ IME: Podcast to Practice podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from Springer Health+ IME: Podcast to Practice podcast

Key Ketone Monitoring Updates and Highlights From the ADA 2025 Conference | S8E1

2025/07/03

Dr. David Kerr discusses breakthrough data from ADA 2025 and the clinical implications for diabetic ketoacidosis management and ketone monitoring technology integration.

Voices of gMG: enhancing patient-centric care

2025/06/03

Janel Worcester-Brown and Dr. Kelly Gwathmey engage in a compelling patient-physician discussion of the realities of living with gMG and the challenges patients face navigating their healthcare journey.

Understanding gMG

2025/06/10

Dr. Kelly Gwathmey and Dr. Sithara Ramdas discuss the clinical presentation, diagnostic challenges, and treatment considerations for both adult and juvenile myasthenia gravis.

New and emerging therapies in gMG: FcRn receptor antagonists and complement inhibition

2025/06/16

Dr. Kelly Gwathmey and Dr. Pushpa Narayanaswami discuss clinical evidence and practical considerations for integrating FcRn antagonists and complement inhibitors into the treatment of gMG.

New and emerging therapies in gMG: going upstream, T-cell and B-cell targeted therapies

2025/06/16

Dr. Kelly Gwathmey and Dr. Pushpa Narayanaswami discuss emerging B- and T-cell targeted therapies for gMG, highlighting recent clinical trials, mechanisms of action, and the evolving treatment paradigm.

Advances in gMG: implications for practice

2025/06/24

Dr. Kelly Gwathmey and Dr. Sithara Ramdas discuss the evolving treatment landscape in gMG, including pediatric-specific considerations.

Embracing gMG advances together: ensuring multidisciplinary collaboration

2025/06/30

Dr. Kelly Gwathmey and Jude Kings discuss the importance of multidisciplinary teamwork in improving outcomes for patients with gMG.

Unveiling the mysteries of molecular testing in AML: a guide for oncologists | S6E1

2025/05/20

Prof. Amer Zeidan and Dr. Sanam Loghavi discuss effective strategies for implementing molecular testing and overcoming barriers in clinical practice for R/R AML.

Advancing AML treatment: evidence-based regimens and guidelines for R/R AML management | S6E2

2025/06/03

Prof. Amer Zeidan and Dr. Eunice Wang discuss the latest evidence-based regimens and guideline updates for the clinical application of targeted therapy in R/R AML.

Deep dive into targeted therapies: understanding IDH1-mutant AML treatments | S6E3

2025/06/16

Prof. Amer Zeidan and Prof. Courtney D. DiNardo discuss the mechanism of action, efficacy, and safety profiles of novel targeted therapies for IDH1-mutant R/R AML.

Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1

2024/07/18

Listen to Professor Tina Vilsbøll provide an overview of diabetic kidney disease (DKD) and the diabetes-cardio-kidney spectrum, as she discusses the importance of proactive identification and management.

Improving recognition, diagnosis and classification of CKD in T2D | S5E2

2024/07/18

Listen to Professor Pinar Topsever discuss the risk factors for CKD in T2D, how to recognise and diagnose CKD in patients with T2D, and the barriers to recognition and diagnosis in practice.

Improving integration of guidelines for CKD in T2D in clinical practice | S5E3

2024/07/18

Learn about evidence-based guidelines for management of CKD in T2D and how these can be integrated into clinical practice with Professor David Cherney

Advances in therapies that work across multiple disease disciplines | S5E4

2024/07/18

Explore advances in therapies available for CKD in T2D and the clinical evidence and guidelines supporting their use with Professor Nilolaus Marx

Importance of interdisciplinary working with the patient at the center | S5E5

2025/02/07

Watch Professor Tina Vilsbøll and patient, Molly Boll, discuss the importance and benefits of effective patient communication, and challenges of SDM in T2D and CKD management.